跳到主要內容

Adma Biologics, Inc.

ADMA
交易所
Nasdaq
產業
Biological Products, (No Diagnostic Substances)
SEC CIK
0001368514

近 90 天,Adma Biologics, Inc. 內部人申報 0 筆公開市場買進、1 筆賣出;2026 年第 2 季末有 322 家機構在 13F 申報持有,市值合計 $17.0 億;杜肯家族辦公室和Fundsmith兩位大師持有。

持有 ADMA 5% 以上的大股東

最新一份 Schedule 13D 或 13G 申報持有 Adma Biologics, Inc. 5% 以上的持有人,依持股比例由大到小;變化是跟這位持有人的上一份申報比。

持有 ADMA 5% 以上的大股東
持有人最新表單持股變化首次申報最新申報原文
BlackRock, Inc.13G/A15.10%股數 3,591 萬–2024/10/72 份2025/4/30SEC
State Street Corp13G6.10%股數 1,368 萬−1.30 個百分點原本 7.40%2024/10/175 份2026/11/10SEC
Vanguard Capital Management LLC13G5.08%股數 1,211 萬新申報2026/4/291 份2026/4/29SEC
Invesco Ltd.13G/A5.00%股數 1,179 萬−0.40 個百分點原本 5.40%2024/11/84 份2026/2/12SEC

持股是每位持有人最新一份申報的數字。最後一份是舊格式(2024 年 12 月 18 日以前)的持有人沒有持股比例紀錄,不列在這裡;公司被收購或下市之後,持有人通常就不再申報。

13D 與 13G 申報

Adma Biologics, Inc. 的 45 份 Schedule 13D、13G 申報,由新到舊,包括沒有持股比例的舊格式申報。

ADMA 的 Schedule 13D、13G 申報
申報時間(美東)申報人表單持股變化事件日原文
2026/11/1006:20 ETState Street Corp13G6.10%股數 1,368 萬−1.30 個百分點原本 7.40%2026/9/30SEC
2026/8/708:23 ETState Street Corp等 2 位13G7.40%股數 1,712 萬+2.30 個百分點原本 5.10%2026/6/30SEC
2026/4/2916:28 ETVanguard Capital Management LLC13G5.08%股數 1,211 萬新申報2026/3/31SEC
2026/3/2615:12 ETVanguard Group Inc13G/A0.00%股數 0−8.94 個百分點原本 8.94%低於 5%2026/3/13SEC
2026/2/1214:56 ETInvesco Ltd.13G/A5.00%股數 1,179 萬−0.40 個百分點原本 5.40%2025/12/31SEC
2025/8/1106:41 ETState Street Corp13G5.10%股數 1,208 萬+0.30 個百分點原本 4.80%2025/6/30SEC
2025/7/2911:22 ETVanguard Group Inc13G/A8.94%股數 2,136 萬–2025/6/30SEC
2025/5/1310:22 ETState Street Corp13G4.80%股數 1,144 萬–低於 5%2025/3/31SEC
2025/5/916:14 ETInvesco Ltd.13G5.40%股數 1,287 萬+0.60 個百分點原本 4.80%2025/3/31SEC
2025/4/3010:29 ETBlackRock, Inc.13G/A15.10%股數 3,591 萬–2025/3/31SEC
2025/2/713:51 ETInvesco Ltd.13G/A4.80%股數 1,130 萬–低於 5%2024/12/31SEC
2024/11/12Vanguard Group Inc13G/A舊制–––SEC
2024/11/8Invesco Ltd.13G舊制–新申報–SEC
2024/11/4Vanguard Group Inc13G舊制–––SEC
2024/10/17State Street Corp13G舊制–新申報–SEC
2024/10/7BlackRock, Inc.13G/A舊制–––SEC
2024/9/23Millennium Management LLC13G舊制–––SEC
2024/3/11Teachers Advisors, LLC13G/A舊制–––SEC
2024/3/11Tiaa Cref Investment Management LLC13G/A舊制–––SEC
2024/3/11Nuveen Asset Management, LLC13G/A舊制–––SEC
2024/2/14Perceptive Advisors LLC13G/A舊制–––SEC
2024/2/14Nuveen Asset Management, LLC13G舊制–––SEC
2024/2/14Teachers Advisors, LLC13G舊制–––SEC
2024/2/14Tiaa Cref Investment Management LLC13G舊制–––SEC
2024/2/13Vanguard Group Inc13G舊制–新申報–SEC
2024/1/2611:49 ETBlackRock Inc.13G/A舊制–––SEC
2023/2/14Perceptive Advisors LLC13G/A舊制–––SEC
2023/2/14Nuveen Asset Management, LLC13G/A舊制–––SEC
2023/2/14Teachers Advisors, LLC13G/A舊制–––SEC
2023/2/14Tiaa Cref Investment Management LLC13G/A舊制–––SEC
2023/2/13Stonepine Capital Management, LLC13G/A舊制–––SEC
2023/2/312:10 ETBlackRock Inc.13G舊制–––SEC
2022/12/9Caligan Partners LP13D/A舊制–––SEC
2022/6/28Millennium Management LLC13G舊制–新申報–SEC
2022/2/15Perceptive Advisors LLC13G/A舊制–––SEC
2022/2/14Consonance Capital Management LP13G/A舊制–––SEC
2022/2/14Stonepine Capital Management, LLC13G/A舊制–––SEC
2022/2/11NWQ Investment Management Company, LLC13G舊制–新申報–SEC
2022/2/4Caligan Partners LP13D舊制–新申報–SEC
2021/12/30Stonepine Capital Management, LLC13G舊制–新申報–SEC
2021/10/27Perceptive Advisors LLC13G/A舊制–––SEC
2021/4/918:02 ETBlackRock Inc.13G/A舊制–––SEC
2021/2/16Perceptive Advisors LLC13G/A舊制–––SEC
2021/2/16Consonance Capital Management LP13G/A舊制–––SEC
2021/2/214:56 ETBlackRock Inc.13G舊制–新申報–SEC

Form 144:內部人預計賣出

高階主管、董事與其他關係人預計賣出 Adma Biologics, Inc. 股票的 22 份通知,由新到舊。

ADMA 的 Form 144
申報時間(美東)賣方預計賣出股數市值預計賣出日券商原文
2026/11/521:00 ETGrossman Adam S.董事 · 高階主管18.9 萬$198.1 萬2026/11/510b5-1Fidelity Brokerage Services, LLCSEC
2026/3/1021:45 ETTade Brad L.前高階主管5.00 萬$79.1 萬2026/3/10Fidelity Brokerage Services, LLCSEC
2026/3/921:00 ETKestenberg-Messina Kaitlin M.高階主管1.01 萬$15.5 萬2026/3/9Fidelity Brokerage Services, LLCSEC
2026/2/1721:02 ETGrossman Adam S.董事 · 高階主管20.9 萬$336.3 萬2026/2/17Fidelity Brokerage Services, LLCSEC
2025/10/2421:00 ETGrossman Adam S.Director and Officer6.30 萬$96.1 萬2025/10/24Fidelity Brokerage Services, LLCSEC
2025/7/1521:01 ETGrossman Adam SDirector and Officer6.30 萬$117.7 萬2025/7/15Fidelity Brokerage Services, LLCSEC
2025/6/1220:33 ETElms Steve董事42.6 萬$930.8 萬2025/6/12Charles SchwabSEC
2025/6/921:00 ETGrossman Jerrold B董事1.00 萬$20.6 萬2025/6/9Fidelity Brokerage Services, LLCSEC
2025/6/413:52 ETLawrence P Guiheen Rev Tr DTD 09/20/19董事2.00 萬$41.5 萬2025/6/4UBS Financial Services IncSEC
2025/5/2121:36 ETGuiheen Lawrence P.董事2.90 萬$57.3 萬2025/5/21Fidelity Brokerage Services, LLCSEC
2025/3/1921:40 ETGrossman Adam SDirector and Officer8.40 萬$157.2 萬2025/3/19Fidelity Brokerage Services, LLCSEC
2024/11/2221:00 ETGrossman Adam SDirector and Officer4.90 萬$104.3 萬2024/11/22Raymond James & Associates, Inc.SEC
2024/11/2221:00 ETTade Brad L.高階主管1.50 萬$31.9 萬2024/11/22Raymond James & Associates, Inc.SEC
2024/9/921:00 ETGuiheen Lawrence P.董事9,000$14.6 萬2024/9/9Raymond James & Associates, Inc.SEC
2024/8/3021:00 ETKestenberg-Messina Kaitlin M.高階主管2.42 萬$41.6 萬2024/8/30Raymond James & Associates, Inc.SEC
2024/8/2921:26 ETGrossman Jerrold B董事13.7 萬$235.9 萬2024/8/29Raymond James & Associates, Inc.SEC
2024/8/2621:28 ETGrossman Adam S高階主管 · 董事62.6 萬$1,140 萬2024/8/26Raymond James & Associates, Inc.SEC
2024/6/1417:15 ETGrossman Adam S高階主管 · 董事50.0 萬$525.0 萬2024/6/1410b5-1Raymond James & Associates, Inc.SEC
2024/3/1316:44 ETAisling Capital II LP關係人150.0 萬$933.0 萬2024/3/13Merrill LynchSEC
2023/8/2217:09 ETBryant FongBoard Member143.3 萬$554.5 萬2023/8/22J.P. Morgan Securities LLCSEC
2023/8/1812:58 ET修正Grossman Adam SOfficer - President and CEO212.0 萬$950.0 萬2023/8/15Raymond James & Associates, Inc.SEC
2023/8/1420:50 ETLenz BrianOFFICER-CFO102.1 萬$457.3 萬2023/8/15Raymond James & Associates, Inc.SEC